EQS-News

Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.

EQS-News: Redcare Pharmacy N.V. / Key word(s): AGM/EGM/Personnel Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board. 18.04.2024 / 09:00 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.

Sevenum, the Netherlands, 18 April, 2024. At Redcare Pharmacy’s Annual General Meeting held yesterday, shareholders voted with an absolute majority for all agenda items, among others the appointment of Dirk Brüse as the new Chief Commercial Officer and Lode Fastré as the company’s new Chief Information Officer.

In addition, former Managing Board members and co-founders Stephan Weber (CCO) and Marc Fischer (CIO) were discharged from liability for the performance of their duties as members of the Managing Board.

As long-standing members of Redcare Pharmacy´s Senior Management Dirk Brüse and Lode Fastré have been mentored by Stephan Weber and Marc Fischer for many years. This transition comes at an ideal time, emphasising Redcare Pharmacy´s commitment to continuity, stability and sustainable growth. Stephan Weber and Marc Fischer will continue to support the company in an advisory capacity until 1 October 2026.

Olaf Heinrich, CEO of Redcare Pharmacy, expresses satisfaction with the investors’ approval stating: "We are very delighted that our shareholders approved the appointment of Dirk Brüse and Lode Fastré. With both, we have two strong leaders from our own ranks who embody the vision and culture of Redcare, along with the expertise to further advance our growth trajectory.”  

Other items on the agenda for this year's Annual General Meeting were the re-appointment of Björn Söder as a member of the Supervisory Board for an additional and fourth term of two years and the re-appointment of Jasper Eenhorst as a member of the Managing Board and CFO of the Company for a further term of four years.

Redcare Pharmacy’s business strategy has again proven successful in the first quarter of this year. The company will release official figures for Q1 on 25 April 2024.